These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3793232)

  • 21. Chlamydia trachomatis pneumonitis in the C57BL/KsJ mouse: pathologic and immunologic features.
    Harrison HR; Lee SM; Lucas DO
    J Lab Clin Med; 1982 Dec; 100(6):953-62. PubMed ID: 7142792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice: natural killer cell activity in cultured spleen leukocytes concomitant with T-cell-dependent immune interferon production.
    Welsh RM; Doe WF
    Infect Immun; 1980 Nov; 30(2):473-83. PubMed ID: 6160108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of gamma-delta T cells in murine Chlamydia trachomatis infection.
    Williams DM; Grubbs BG; Kelly K; Pack E; Rank RG
    Infect Immun; 1996 Sep; 64(9):3916-9. PubMed ID: 8751950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of antibody in host defense against the agent of mouse pneumonitis.
    Williams DM; Schachter J; Grubbs B; Sumaya CV
    J Infect Dis; 1982 Feb; 145(2):200-5. PubMed ID: 7054323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Murine pulmonary NK activity and its augmentation by Poly I:C and IL-2].
    Iwata M; Sato M; Maruyama M; Mizushima Y; Sugiyama E; Yamashita N; Suzuki H; Yano S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Mar; 24(3):213-7. PubMed ID: 3488461
    [No Abstract]   [Full Text] [Related]  

  • 26. Production of colony-stimulating factors during pneumonia caused by Chlamydia trachomatis.
    Magee DM; Williams DM; Wing EJ; Bleicker CA; Schachter J
    Infect Immun; 1991 Jul; 59(7):2370-5. PubMed ID: 1828791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innate immunity in defense against Chlamydia trachomatis infections.
    Severin JA; Ossewaarde JM
    Drugs Today (Barc); 2006 Mar; 42 Suppl A():75-81. PubMed ID: 16683047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GM-CSF transgene-based adjuvant allows the establishment of protective mucosal immunity following vaccination with inactivated Chlamydia trachomatis.
    Lu H; Xing Z; Brunham RC
    J Immunol; 2002 Dec; 169(11):6324-31. PubMed ID: 12444139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary murine Chlamydia trachomatis pneumonia in B-cell-deficient mice.
    Williams DM; Grubbs B; Schachter J
    Infect Immun; 1987 Oct; 55(10):2387-90. PubMed ID: 3498690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Chlamydia trachomatis infection on the expression of natural killer (NK) cell ligands and susceptibility to NK cell lysis.
    Hook CE; Telyatnikova N; Goodall JC; Braud VM; Carmichael AJ; Wills MR; Gaston JS
    Clin Exp Immunol; 2004 Oct; 138(1):54-60. PubMed ID: 15373905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis of natural killer function in lung, spleen, and peripheral blood lymphocytes: evidence of differential characteristics.
    Lauzon W; Yang H; Lemaire I
    Reg Immunol; 1990-1991; 3(3):145-50. PubMed ID: 2129104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role for CD8+ T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones.
    Igietseme JU; Magee DM; Williams DM; Rank RG
    Infect Immun; 1994 Nov; 62(11):5195-7. PubMed ID: 7927806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The activity of natural cytotoxic cells is augmented by interleukin 2 and interleukin 3.
    Lattime EC; Pecoraro GA; Stutman O
    J Exp Med; 1983 Mar; 157(3):1070-5. PubMed ID: 6403648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered natural killer and natural cytotoxic cellular activities in lpr mice.
    Pan LZ; Dauphinée MJ; Ansar Ahmed S; Talal N
    Scand J Immunol; 1986 Apr; 23(4):415-23. PubMed ID: 3486460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic chlamydial genital infection in congenitally athymic nude mice.
    Rank RG; Soderberg LS; Barron AL
    Infect Immun; 1985 Jun; 48(3):847-9. PubMed ID: 3997251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of natural killer cells in the destruction of circulating tumor emboli.
    Hanna N; Fidler IJ
    J Natl Cancer Inst; 1980 Oct; 65(4):801-9. PubMed ID: 6932529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection.
    Ramsey KH; Cotter TW; Salyer RD; Miranpuri GS; Yanez MA; Poulsen CE; DeWolfe JL; Byrne GI
    Infect Immun; 1999 Jun; 67(6):3019-25. PubMed ID: 10338514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon in recovery from pneumonia due to Chlamydia trachomatis in the mouse.
    Byrne GI; Grubbs B; Dickey TJ; Schachter J; Williams DM
    J Infect Dis; 1987 Dec; 156(6):993-6. PubMed ID: 3119732
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro effects of Mycoplasma pulmonis on murine natural killer cell activity.
    Swing SP; Davis JK; Egan ML
    Lab Anim Sci; 1995 Aug; 45(4):352-6. PubMed ID: 7474870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysis of a lung carcinoma by poly I:C-induced natural killer cells is independent of the expression of class I histocompatibility antigens.
    Dennert G; Landon C; Lord EM; Bahler DW; Frelinger JG
    J Immunol; 1988 Apr; 140(7):2472-5. PubMed ID: 3351305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.